First Time Loading...

Mediwound Ltd
NASDAQ:MDWD

Watchlist Manager
Mediwound Ltd Logo
Mediwound Ltd
NASDAQ:MDWD
Watchlist
Price: 17.32 USD -2.2% Market Closed
Updated: May 11, 2024
Section:
 

Wall Street
Price Targets

MDWD Price Targets Summary
Mediwound Ltd

Wall Street analysts forecast MDWD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDWD is 29.07 USD with a low forecast of 25.25 USD and a high forecast of 37.8 USD.

MDWD Lowest Forecast
Wall Street Target
25.25 USD
46% Upside
MDWD Average Forecast
Wall Street Target
29.07 USD
68% Upside
MDWD Highest Forecast
Wall Street Target
37.8 USD
118% Upside
Lowest
Price Target
25.25 USD
46% Upside
Average
Price Target
29.07 USD
68% Upside
Highest
Price Target
37.8 USD
118% Upside
Mediwound Ltd Competitors:
Price Targets
000999
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
15% Upside
TARO
Taro Pharmaceutical Industries Ltd
4% Upside
C
CONCORDBIO
Concord Biotech Ltd
6% Upside
D
DPHARMA
Duopharma Biotech Bhd
21% Upside
000999
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
15% Upside
TARO
Taro Pharmaceutical Industries Ltd
4% Upside
C
CONCORDBIO
Concord Biotech Ltd
6% Upside
D
DPHARMA
Duopharma Biotech Bhd
21% Upside
SEQUENT
SeQuent Scientific Ltd
13% Upside
HCM
HUTCHMED (China) Ltd
7% Upside
300006
Chongqing Lummy Pharmaceutical Co Ltd
259% Upside
600285
Henan Lingrui Pharmaceutical Co Ltd
53% Downside

Revenue
Forecast

Revenue Estimate
Mediwound Ltd

For the last 8 years the compound annual growth rate for Mediwound Ltd's revenue is 54%. The projected CAGR for the next 3 years is 43%.

54%
Past Growth
43%
Estimated Growth
Estimates Accuracy
2%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Mediwound Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Mediwound Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-64%
Average Miss
What are analyst estimates?

See Also

Summary
MDWD intrinsic value, competitors valuation, and company profile.
DCF Valuation
MDWD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MDWD stock valuation using valuation multiples.
Wall Street Estimates
MDWD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MDWD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDWD's stock price target?
Price Target
29.07 USD

According to Wall Street analysts, the average 1-year price target for MDWD is 29.07 USD with a low forecast of 25.25 USD and a high forecast of 37.8 USD.

What is Mediwound Ltd's Revenue forecast?
Projected CAGR
43%

For the last 8 years the compound annual growth rate for Mediwound Ltd's revenue is 54%. The projected CAGR for the next 3 years is 43%.

ALPHA SPREAD
Join more than 136,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.